img

Global Expression Competent Cells Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Expression Competent Cells Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

The Protein Expression Competent Cell Pack lets you efficiently economically optimize expression by simultaneously testing multiple strains with your gene of interest. The pack includes BL21(DE3) competent cells for nontoxic proteins and BL21(DE3) pLysS competent cells for both toxic and nontoxic proteins.
Expression Competent Cells report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Expression Competent Cells market is projected to reach US$ 746.9 million in 2033, increasing from US$ 382.5 million in 2022, with the CAGR of 10.1% during the period of 2023 to 2033. Demand from Protein Expression and Other are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Expression Competent Cells industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Expression Competent Cells key companies include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. Merck KGaA, Thermo Fisher Scientific, Agilent Technologies are top 3 players and held % share in total in 2022.
Expression Competent Cells can be divided into Chemically Competent Cells and Electrocompetent Cells, etc. Chemically Competent Cells is the mainstream product in the market, accounting for % share globally in 2022.
Expression Competent Cells is widely used in various fields, such as Protein Expression and Other, etc. Protein Expression provides greatest supports to the Expression Competent Cells industry development. In 2022, global % share of Expression Competent Cells went into Protein Expression filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Expression Competent Cells market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Chemically Competent Cells
Electrocompetent Cells

Segment by Application


Protein Expression
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Expression Competent Cells market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Expression Competent Cells introduction, etc. Expression Competent Cells Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Expression Competent Cells market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Expression Competent Cells
1.1 Expression Competent Cells Market Overview
1.1.1 Expression Competent Cells Product Scope
1.1.2 Expression Competent Cells Market Status and Outlook
1.2 Global Expression Competent Cells Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Expression Competent Cells Market Size by Region (2018-2033)
1.4 Global Expression Competent Cells Historic Market Size by Region (2018-2023)
1.5 Global Expression Competent Cells Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Expression Competent Cells Market Size (2018-2033)
1.6.1 North America Expression Competent Cells Market Size (2018-2033)
1.6.2 Europe Expression Competent Cells Market Size (2018-2033)
1.6.3 Asia-Pacific Expression Competent Cells Market Size (2018-2033)
1.6.4 Latin America Expression Competent Cells Market Size (2018-2033)
1.6.5 Middle East & Africa Expression Competent Cells Market Size (2018-2033)
2 Expression Competent Cells Market by Type
2.1 Introduction
2.1.1 Chemically Competent Cells
2.1.2 Electrocompetent Cells
2.2 Global Expression Competent Cells Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Expression Competent Cells Historic Market Size by Type (2018-2023)
2.2.2 Global Expression Competent Cells Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Expression Competent Cells Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Expression Competent Cells Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Expression Competent Cells Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Expression Competent Cells Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Expression Competent Cells Revenue Breakdown by Type (2018-2033)
3 Expression Competent Cells Market Overview by Application
3.1 Introduction
3.1.1 Protein Expression
3.1.2 Other
3.2 Global Expression Competent Cells Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Expression Competent Cells Historic Market Size by Application (2018-2023)
3.2.2 Global Expression Competent Cells Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Expression Competent Cells Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Expression Competent Cells Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Expression Competent Cells Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Expression Competent Cells Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Expression Competent Cells Revenue Breakdown by Application (2018-2033)
4 Expression Competent Cells Competition Analysis by Players
4.1 Global Expression Competent Cells Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Expression Competent Cells as of 2022)
4.3 Date of Key Players Enter into Expression Competent Cells Market
4.4 Global Top Players Expression Competent Cells Headquarters and Area Served
4.5 Key Players Expression Competent Cells Product Solution and Service
4.6 Competitive Status
4.6.1 Expression Competent Cells Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck KGaA
5.1.1 Merck KGaA Profile
5.1.2 Merck KGaA Main Business
5.1.3 Merck KGaA Expression Competent Cells Products, Services and Solutions
5.1.4 Merck KGaA Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.1.5 Merck KGaA Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Expression Competent Cells Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Agilent Technologies
5.3.1 Agilent Technologies Profile
5.3.2 Agilent Technologies Main Business
5.3.3 Agilent Technologies Expression Competent Cells Products, Services and Solutions
5.3.4 Agilent Technologies Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.3.5 Takara Bio Recent Developments
5.4 Takara Bio
5.4.1 Takara Bio Profile
5.4.2 Takara Bio Main Business
5.4.3 Takara Bio Expression Competent Cells Products, Services and Solutions
5.4.4 Takara Bio Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.4.5 Takara Bio Recent Developments
5.5 Promega Corporation
5.5.1 Promega Corporation Profile
5.5.2 Promega Corporation Main Business
5.5.3 Promega Corporation Expression Competent Cells Products, Services and Solutions
5.5.4 Promega Corporation Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.5.5 Promega Corporation Recent Developments
5.6 Beijing TransGen Biotech
5.6.1 Beijing TransGen Biotech Profile
5.6.2 Beijing TransGen Biotech Main Business
5.6.3 Beijing TransGen Biotech Expression Competent Cells Products, Services and Solutions
5.6.4 Beijing TransGen Biotech Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.6.5 Beijing TransGen Biotech Recent Developments
5.7 GeneScript Corporation
5.7.1 GeneScript Corporation Profile
5.7.2 GeneScript Corporation Main Business
5.7.3 GeneScript Corporation Expression Competent Cells Products, Services and Solutions
5.7.4 GeneScript Corporation Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.7.5 GeneScript Corporation Recent Developments
5.8 Yeastern Biotech
5.8.1 Yeastern Biotech Profile
5.8.2 Yeastern Biotech Main Business
5.8.3 Yeastern Biotech Expression Competent Cells Products, Services and Solutions
5.8.4 Yeastern Biotech Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.8.5 Yeastern Biotech Recent Developments
5.9 New England Biolabs
5.9.1 New England Biolabs Profile
5.9.2 New England Biolabs Main Business
5.9.3 New England Biolabs Expression Competent Cells Products, Services and Solutions
5.9.4 New England Biolabs Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.9.5 New England Biolabs Recent Developments
5.10 QIAGEN N.V.
5.10.1 QIAGEN N.V. Profile
5.10.2 QIAGEN N.V. Main Business
5.10.3 QIAGEN N.V. Expression Competent Cells Products, Services and Solutions
5.10.4 QIAGEN N.V. Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.10.5 QIAGEN N.V. Recent Developments
5.11 OriGene Technologies
5.11.1 OriGene Technologies Profile
5.11.2 OriGene Technologies Main Business
5.11.3 OriGene Technologies Expression Competent Cells Products, Services and Solutions
5.11.4 OriGene Technologies Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.11.5 OriGene Technologies Recent Developments
5.12 Lucigen
5.12.1 Lucigen Profile
5.12.2 Lucigen Main Business
5.12.3 Lucigen Expression Competent Cells Products, Services and Solutions
5.12.4 Lucigen Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.12.5 Lucigen Recent Developments
5.13 Zymo Research
5.13.1 Zymo Research Profile
5.13.2 Zymo Research Main Business
5.13.3 Zymo Research Expression Competent Cells Products, Services and Solutions
5.13.4 Zymo Research Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.13.5 Zymo Research Recent Developments
5.14 Bio-Rad Laboratories
5.14.1 Bio-Rad Laboratories Profile
5.14.2 Bio-Rad Laboratories Main Business
5.14.3 Bio-Rad Laboratories Expression Competent Cells Products, Services and Solutions
5.14.4 Bio-Rad Laboratories Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.14.5 Bio-Rad Laboratories Recent Developments
5.15 Bioline
5.15.1 Bioline Profile
5.15.2 Bioline Main Business
5.15.3 Bioline Expression Competent Cells Products, Services and Solutions
5.15.4 Bioline Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.15.5 Bioline Recent Developments
5.16 Delphi Genetics
5.16.1 Delphi Genetics Profile
5.16.2 Delphi Genetics Main Business
5.16.3 Delphi Genetics Expression Competent Cells Products, Services and Solutions
5.16.4 Delphi Genetics Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.16.5 Delphi Genetics Recent Developments
5.17 IBA GmBH
5.17.1 IBA GmBH Profile
5.17.2 IBA GmBH Main Business
5.17.3 IBA GmBH Expression Competent Cells Products, Services and Solutions
5.17.4 IBA GmBH Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.17.5 IBA GmBH Recent Developments
5.18 Cell Applications
5.18.1 Cell Applications Profile
5.18.2 Cell Applications Main Business
5.18.3 Cell Applications Expression Competent Cells Products, Services and Solutions
5.18.4 Cell Applications Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.18.5 Cell Applications Recent Developments
5.19 BioDynamics Laboratory
5.19.1 BioDynamics Laboratory Profile
5.19.2 BioDynamics Laboratory Main Business
5.19.3 BioDynamics Laboratory Expression Competent Cells Products, Services and Solutions
5.19.4 BioDynamics Laboratory Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.19.5 BioDynamics Laboratory Recent Developments
5.20 Scarab Genomics
5.20.1 Scarab Genomics Profile
5.20.2 Scarab Genomics Main Business
5.20.3 Scarab Genomics Expression Competent Cells Products, Services and Solutions
5.20.4 Scarab Genomics Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.20.5 Scarab Genomics Recent Developments
6 North America
6.1 North America Expression Competent Cells Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Expression Competent Cells Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Expression Competent Cells Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Expression Competent Cells Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Expression Competent Cells Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Expression Competent Cells Market Dynamics
11.1 Expression Competent Cells Industry Trends
11.2 Expression Competent Cells Market Drivers
11.3 Expression Competent Cells Market Challenges
11.4 Expression Competent Cells Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Expression Competent Cells Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Expression Competent Cells Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Expression Competent Cells Market Size Share by Region (2018-2023)
Table 4. Global Expression Competent Cells Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Expression Competent Cells Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Expression Competent Cells Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Expression Competent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Expression Competent Cells Revenue Market Share by Type (2018-2023)
Table 9. Global Expression Competent Cells Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Expression Competent Cells Revenue Market Share by Type (2024-2033)
Table 11. North America Expression Competent Cells Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Expression Competent Cells Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Expression Competent Cells Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Expression Competent Cells Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Expression Competent Cells Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Expression Competent Cells Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Expression Competent Cells Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Expression Competent Cells Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Expression Competent Cells Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Expression Competent Cells Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Expression Competent Cells Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Expression Competent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Expression Competent Cells Revenue Market Share by Application (2018-2023)
Table 24. Global Expression Competent Cells Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Expression Competent Cells Revenue Market Share by Application (2024-2033)
Table 26. North America Expression Competent Cells Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Expression Competent Cells Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Expression Competent Cells Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Expression Competent Cells Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Expression Competent Cells Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Expression Competent Cells Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Expression Competent Cells Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Expression Competent Cells Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Expression Competent Cells Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Expression Competent Cells Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Expression Competent Cells Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Expression Competent Cells Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Expression Competent Cells as of 2022)
Table 39. Date of Key Players Enter into Expression Competent Cells Market
Table 40. Global Expression Competent Cells Key Players Headquarters and Area Served
Table 41. Expression Competent Cells Product Solution and Service
Table 42. Global Expression Competent Cells Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Merck KGaA Basic Information List
Table 45. Merck KGaA Description and Business Overview
Table 46. Merck KGaA Expression Competent Cells Products, Services and Solutions
Table 47. Revenue (US$ Million) in Expression Competent Cells Business of Merck KGaA (2018-2023)
Table 48. Merck KGaA Recent Developments
Table 49. Thermo Fisher Scientific Basic Information List
Table 50. Thermo Fisher Scientific Description and Business Overview
Table 51. Thermo Fisher Scientific Expression Competent Cells Products, Services and Solutions
Table 52. Revenue (US$ Million) in Expression Competent Cells Business of Thermo Fisher Scientific (2018-2023)
Table 53. Thermo Fisher Scientific Recent Developments
Table 54. Agilent Technologies Basic Information List
Table 55. Agilent Technologies Description and Business Overview
Table 56. Agilent Technologies Expression Competent Cells Products, Services and Solutions
Table 57. Revenue (US$ Million) in Expression Competent Cells Business of Agilent Technologies (2018-2023)
Table 58. Agilent Technologies Recent Developments
Table 59. Takara Bio Basic Information List
Table 60. Takara Bio Description and Business Overview
Table 61. Takara Bio Expression Competent Cells Products, Services and Solutions
Table 62. Revenue (US$ Million) in Expression Competent Cells Business of Takara Bio (2018-2023)
Table 63. Takara Bio Recent Developments
Table 64. Promega Corporation Basic Information List
Table 65. Promega Corporation Description and Business Overview
Table 66. Promega Corporation Expression Competent Cells Products, Services and Solutions
Table 67. Revenue (US$ Million) in Expression Competent Cells Business of Promega Corporation (2018-2023)
Table 68. Promega Corporation Recent Developments
Table 69. Beijing TransGen Biotech Basic Information List
Table 70. Beijing TransGen Biotech Description and Business Overview
Table 71. Beijing TransGen Biotech Expression Competent Cells Products, Services and Solutions
Table 72. Revenue (US$ Million) in Expression Competent Cells Business of Beijing TransGen Biotech (2018-2023)
Table 73. Beijing TransGen Biotech Recent Developments
Table 74. GeneScript Corporation Basic Information List
Table 75. GeneScript Corporation Description and Business Overview
Table 76. GeneScript Corporation Expression Competent Cells Products, Services and Solutions
Table 77. Revenue (US$ Million) in Expression Competent Cells Business of GeneScript Corporation (2018-2023)
Table 78. GeneScript Corporation Recent Developments
Table 79. Yeastern Biotech Basic Information List
Table 80. Yeastern Biotech Description and Business Overview
Table 81. Yeastern Biotech Expression Competent Cells Products, Services and Solutions
Table 82. Revenue (US$ Million) in Expression Competent Cells Business of Yeastern Biotech (2018-2023)
Table 83. Yeastern Biotech Recent Developments
Table 84. New England Biolabs Basic Information List
Table 85. New England Biolabs Description and Business Overview
Table 86. New England Biolabs Expression Competent Cells Products, Services and Solutions
Table 87. Revenue (US$ Million) in Expression Competent Cells Business of New England Biolabs (2018-2023)
Table 88. New England Biolabs Recent Developments
Table 89. QIAGEN N.V. Basic Information List
Table 90. QIAGEN N.V. Description and Business Overview
Table 91. QIAGEN N.V. Expression Competent Cells Products, Services and Solutions
Table 92. Revenue (US$ Million) in Expression Competent Cells Business of QIAGEN N.V. (2018-2023)
Table 93. QIAGEN N.V. Recent Developments
Table 94. OriGene Technologies Basic Information List
Table 95. OriGene Technologies Description and Business Overview
Table 96. OriGene Technologies Expression Competent Cells Products, Services and Solutions
Table 97. Revenue (US$ Million) in Expression Competent Cells Business of OriGene Technologies (2018-2023)
Table 98. OriGene Technologies Recent Developments
Table 99. Lucigen Basic Information List
Table 100. Lucigen Description and Business Overview
Table 101. Lucigen Expression Competent Cells Products, Services and Solutions
Table 102. Revenue (US$ Million) in Expression Competent Cells Business of Lucigen (2018-2023)
Table 103. Lucigen Recent Developments
Table 104. Zymo Research Basic Information List
Table 105. Zymo Research Description and Business Overview
Table 106. Zymo Research Expression Competent Cells Products, Services and Solutions
Table 107. Revenue (US$ Million) in Expression Competent Cells Business of Zymo Research (2018-2023)
Table 108. Zymo Research Recent Developments
Table 109. Bio-Rad Laboratories Basic Information List
Table 110. Bio-Rad Laboratories Description and Business Overview
Table 111. Bio-Rad Laboratories Expression Competent Cells Products, Services and Solutions
Table 112. Revenue (US$ Million) in Expression Competent Cells Business of Bio-Rad Laboratories (2018-2023)
Table 113. Bio-Rad Laboratories Recent Developments
Table 114. Bioline Basic Information List
Table 115. Bioline Description and Business Overview
Table 116. Bioline Expression Competent Cells Products, Services and Solutions
Table 117. Revenue (US$ Million) in Expression Competent Cells Business of Bioline (2018-2023)
Table 118. Bioline Recent Developments
Table 119. Delphi Genetics Basic Information List
Table 120. Delphi Genetics Description and Business Overview
Table 121. Delphi Genetics Expression Competent Cells Products, Services and Solutions
Table 122. Revenue (US$ Million) in Expression Competent Cells Business of Delphi Genetics (2018-2023)
Table 123. Delphi Genetics Recent Developments
Table 124. IBA GmBH Basic Information List
Table 125. IBA GmBH Description and Business Overview
Table 126. IBA GmBH Expression Competent Cells Products, Services and Solutions
Table 127. Revenue (US$ Million) in Expression Competent Cells Business of IBA GmBH (2018-2023)
Table 128. IBA GmBH Recent Developments
Table 129. Cell Applications Basic Information List
Table 130. Cell Applications Description and Business Overview
Table 131. Cell Applications Expression Competent Cells Products, Services and Solutions
Table 132. Revenue (US$ Million) in Expression Competent Cells Business of Cell Applications (2018-2023)
Table 133. Cell Applications Recent Developments
Table 134. BioDynamics Laboratory Basic Information List
Table 135. BioDynamics Laboratory Description and Business Overview
Table 136. BioDynamics Laboratory Expression Competent Cells Products, Services and Solutions
Table 137. Revenue (US$ Million) in Expression Competent Cells Business of BioDynamics Laboratory (2018-2023)
Table 138. BioDynamics Laboratory Recent Developments
Table 139. Scarab Genomics Basic Information List
Table 140. Scarab Genomics Description and Business Overview
Table 141. Scarab Genomics Expression Competent Cells Products, Services and Solutions
Table 142. Revenue (US$ Million) in Expression Competent Cells Business of Scarab Genomics (2018-2023)
Table 143. Scarab Genomics Recent Developments
Table 144. North America Expression Competent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 145. North America Expression Competent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 146. Europe Expression Competent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 147. Europe Expression Competent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 148. Asia-Pacific Expression Competent Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 149. Asia-Pacific Expression Competent Cells Market Size by Region (2018-2023) & (US$ Million)
Table 150. Asia-Pacific Expression Competent Cells Market Size by Region (2024-2033) & (US$ Million)
Table 151. Asia-Pacific Expression Competent Cells Market Share by Region (2018-2023)
Table 152. Asia-Pacific Expression Competent Cells Market Share by Region (2024-2033)
Table 153. Latin America Expression Competent Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 154. Latin America Expression Competent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 155. Latin America Expression Competent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 156. Middle East & Africa Expression Competent Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 157. Middle East & Africa Expression Competent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 158. Middle East & Africa Expression Competent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 159. Expression Competent Cells Market Trends
Table 160. Expression Competent Cells Market Drivers
Table 161. Expression Competent Cells Market Challenges
Table 162. Expression Competent Cells Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Expression Competent Cells Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Expression Competent Cells Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Expression Competent Cells Market Share by Regions: 2022 VS 2033
Figure 4. Global Expression Competent Cells Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Expression Competent Cells Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Expression Competent Cells Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Expression Competent Cells Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Expression Competent Cells Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Expression Competent Cells Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Chemically Competent Cells
Figure 11. Global Chemically Competent Cells Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Electrocompetent Cells
Figure 13. Global Electrocompetent Cells Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Expression Competent Cells Market Size Share by Type: 2022 & 2033
Figure 15. North America Expression Competent Cells Revenue Market Share by Type (2018-2033)
Figure 16. Europe Expression Competent Cells Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Expression Competent Cells Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Expression Competent Cells Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Expression Competent Cells Revenue Market Share by Type (2018-2033)
Figure 20. Protein Expression Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Other Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Global Expression Competent Cells Market Size Share by Application: 2022 & 2033
Figure 23. North America Expression Competent Cells Revenue Market Share by Application (2018-2033)
Figure 24. Europe Expression Competent Cells Revenue Market Share by Application (2018-2033)
Figure 25. Asia-Pacific Expression Competent Cells Revenue Market Share by Application (2018-2033)
Figure 26. Latin America Expression Competent Cells Revenue Market Share by Application (2018-2033)
Figure 27. Middle East and Africa Expression Competent Cells Revenue Market Share by Application (2018-2033)
Figure 28. Expression Competent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 29. Global Top 5 and Top 10 Players Expression Competent Cells Market Share in 2022
Figure 30. North America Expression Competent Cells Market Share by Country (2018-2033)
Figure 31. U.S. Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 32. Canada Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 33. Germany Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 34. France Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 35. U.K. Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 36. Italy Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 37. Russia Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 38. Nordic Countries Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 39. Asia-Pacific Expression Competent Cells Market Share by Region (2018-2033)
Figure 40. China Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 41. Japan Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 42. South Korea Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 44. India Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 45. Australia Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 46. Latin America Expression Competent Cells Market Share by Country (2018-2033)
Figure 47. Mexico Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 48. Brazil Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 49. Middle East & Africa Expression Competent Cells Market Share by Country (2018-2033)
Figure 50. Turkey Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 51. Saudi Arabia Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 52. UAE Expression Competent Cells Market Size (2018-2033) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report